• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

程序性死亡-1受体的缺失通过白细胞介素-2依赖机制完全逆转已建立的CD4(+) T淋巴细胞克隆无能。

Depletion of the programmed death-1 receptor completely reverses established clonal anergy in CD4(+) T lymphocytes via an interleukin-2-dependent mechanism.

作者信息

Bishop Kenneth D, Harris John E, Mordes John P, Greiner Dale L, Rossini Aldo A, Czech Michael P, Phillips Nancy E

机构信息

University of Massachusetts Medical School, Worcester, 01655, USA.

出版信息

Cell Immunol. 2009;256(1-2):86-91. doi: 10.1016/j.cellimm.2009.01.008. Epub 2009 Feb 23.

DOI:10.1016/j.cellimm.2009.01.008
PMID:19230866
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2876711/
Abstract

Recent studies have implicated the cell surface receptor Programmed Death-1 (PD-1) in numerous models of T cell anergy, though the specific mechanisms by which the PD-1 signal maintains tolerance is not clear. We demonstrate that the depletion of PD-1 with siRNA results in a complete reversal of clonal anergy in the A.E7 T cell model, suggesting that the mechanism by which PD-1 maintains the anergic phenotype is a T-cell-intrinsic phenomenon, and not one dependent on other cell populations in vivo. We have also shown that the neutralization of IL-2 during restimulation abrogates the effect of PD-1 depletion, suggesting that tolerance mediated by PD-1 is wholly IL-2 dependent, and likewise intrinsic to the tolerized cells.

摘要

近期研究表明,细胞表面受体程序性死亡蛋白1(PD-1)在众多T细胞无能模型中发挥作用,不过PD-1信号维持免疫耐受的具体机制尚不清楚。我们证明,在A.E7 T细胞模型中,用小干扰RNA(siRNA)去除PD-1可使克隆无能完全逆转,这表明PD-1维持无能表型的机制是一种T细胞内在现象,而非依赖体内其他细胞群体。我们还表明,在再次刺激期间中和白细胞介素-2(IL-2)可消除去除PD-1的效果,这表明由PD-1介导的免疫耐受完全依赖IL-2,同样也是耐受细胞所固有的。

相似文献

1
Depletion of the programmed death-1 receptor completely reverses established clonal anergy in CD4(+) T lymphocytes via an interleukin-2-dependent mechanism.程序性死亡-1受体的缺失通过白细胞介素-2依赖机制完全逆转已建立的CD4(+) T淋巴细胞克隆无能。
Cell Immunol. 2009;256(1-2):86-91. doi: 10.1016/j.cellimm.2009.01.008. Epub 2009 Feb 23.
2
Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance.程序性细胞死亡蛋白1(PD-1)及其配体PD-L1是同种异体移植耐受所必需的。
Eur J Immunol. 2007 Oct;37(10):2983-90. doi: 10.1002/eji.200737583.
3
Early growth response gene-2, a zinc-finger transcription factor, is required for full induction of clonal anergy in CD4+ T cells.早期生长反应基因-2,一种锌指转录因子,是CD4 + T细胞中克隆无能完全诱导所必需的。
J Immunol. 2004 Dec 15;173(12):7331-8. doi: 10.4049/jimmunol.173.12.7331.
4
PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells.程序性死亡蛋白1/程序性死亡配体阻断可防止无能诱导,并增强糖脂激活的不变自然杀伤T细胞的抗肿瘤活性。
J Immunol. 2009 Mar 1;182(5):2816-26. doi: 10.4049/jimmunol.0803648.
5
Forced expression of programmed death-1 gene on T cell decreased the incidence of type 1 diabetes.强制表达程序性死亡受体 1 基因可降低 1 型糖尿病的发病率。
Arch Pharm Res. 2010 Nov;33(11):1825-33. doi: 10.1007/s12272-010-1115-3. Epub 2010 Nov 30.
6
The avidity spectrum of T cell receptor interactions accounts for T cell anergy in a double transgenic model.在双转基因模型中,T细胞受体相互作用的亲和力谱决定了T细胞无能。
J Exp Med. 1999 Jan 18;189(2):265-78. doi: 10.1084/jem.189.2.265.
7
Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation.程序性细胞死亡受体 1 通路的损伤会增加动脉粥样硬化病变的发展和炎症。
Arterioscler Thromb Vasc Biol. 2011 May;31(5):1100-7. doi: 10.1161/ATVBAHA.111.224709. Epub 2011 Mar 10.
8
Induction of responsiveness in superantigen-induced anergic T cells. Role of ligand density and costimulatory signals.超抗原诱导的无反应性T细胞反应性的诱导。配体密度和共刺激信号的作用。
J Immunol. 1995 Jul 1;155(1):83-92.
9
Fas/Fas ligand pathway, apoptosis, and clonal anergy involved in systemic acetylcholine receptor T cell epitope tolerance.Fas/Fas配体途径、细胞凋亡以及克隆无能参与全身性乙酰胆碱受体T细胞表位耐受。
J Immunol. 2001 Mar 1;166(5):3458-67. doi: 10.4049/jimmunol.166.5.3458.
10
IL-2 unresponsiveness in anergic CD4+ T cells is due to defective signaling through the common gamma-chain of the IL-2 receptor.无反应性CD4+ T细胞中白细胞介素-2无反应性是由于通过白细胞介素-2受体共同γ链的信号传导缺陷所致。
J Immunol. 2000 Feb 1;164(3):1175-84. doi: 10.4049/jimmunol.164.3.1175.

引用本文的文献

1
Programmed Cell Death-Ligand 1 in Head and Neck Squamous Cell Carcinoma: Molecular Insights, Preclinical and Clinical Data, and Therapies.程序性细胞死亡配体 1 在下咽鳞状细胞癌中的作用:分子见解、临床前和临床数据以及治疗方法。
Int J Mol Sci. 2022 Dec 6;23(23):15384. doi: 10.3390/ijms232315384.
2
Probiotic-Induced Tolerogenic Dendritic Cells: A Novel Therapy for Inflammatory Bowel Disease?益生菌诱导的耐受树突状细胞:炎症性肠病的一种新疗法?
Int J Mol Sci. 2021 Jul 31;22(15):8274. doi: 10.3390/ijms22158274.
3
Manipulation of Regulatory Dendritic Cells for Induction Transplantation Tolerance.调控树突状细胞诱导移植耐受的研究进展
Front Immunol. 2020 Oct 14;11:582658. doi: 10.3389/fimmu.2020.582658. eCollection 2020.
4
Dysregulation of the PD-1/PD-L1 pathway contributes to the pathogenesis of celiac disease.PD-1/PD-L1通路的失调促成了乳糜泻的发病机制。
Cell Mol Immunol. 2019 Sep;16(9):777-779. doi: 10.1038/s41423-019-0256-7. Epub 2019 Jun 26.
5
Mechanisms of Tolerance Induction by Dendritic Cells .树突状细胞诱导耐受的机制。
Front Immunol. 2018 Feb 26;9:350. doi: 10.3389/fimmu.2018.00350. eCollection 2018.
6
Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer.可溶性程序性死亡受体-1和程序性死亡配体-1:在癌症中的预测和预后意义
Oncotarget. 2017 May 31;8(57):97671-97682. doi: 10.18632/oncotarget.18311. eCollection 2017 Nov 14.
7
PD-1 and its ligands are important immune checkpoints in cancer.程序性死亡受体1(PD-1)及其配体是癌症中重要的免疫检查点。
Oncotarget. 2017 Jan 10;8(2):2171-2186. doi: 10.18632/oncotarget.13895.
8
Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated Immunosuppression.间充质基质细胞分泌程序性死亡-1配体调节T细胞介导的免疫抑制。
Stem Cells. 2017 Mar;35(3):766-776. doi: 10.1002/stem.2509. Epub 2016 Oct 26.
9
miR-28 modulates exhaustive differentiation of T cells through silencing programmed cell death-1 and regulating cytokine secretion.微小RNA-28通过沉默程序性细胞死亡蛋白1和调节细胞因子分泌来调控T细胞的彻底分化。
Oncotarget. 2016 Aug 16;7(33):53735-53750. doi: 10.18632/oncotarget.10731.
10
Therapeutic Potential of Hyporesponsive CD4(+) T Cells in Autoimmunity.低反应性CD4(+) T细胞在自身免疫中的治疗潜力
Front Immunol. 2015 Sep 22;6:488. doi: 10.3389/fimmu.2015.00488. eCollection 2015.

本文引用的文献

1
Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.通过CTLA-4和PD-1途径控制外周T细胞耐受性和自身免疫
Immunol Rev. 2008 Aug;224:166-82. doi: 10.1111/j.1600-065X.2008.00662.x.
2
PD-1 and its ligands in tolerance and immunity.PD-1及其配体在免疫耐受与免疫中的作用
Annu Rev Immunol. 2008;26:677-704. doi: 10.1146/annurev.immunol.26.021607.090331.
3
Antibody-mediated signaling through PD-1 costimulates T cells and enhances CD28-dependent proliferation.通过程序性死亡受体1(PD-1)的抗体介导信号传导共刺激T细胞并增强依赖于CD28的增殖。
Eur J Immunol. 2005 Dec;35(12):3545-60. doi: 10.1002/eji.200535232.
4
PD-L2:PD-1 involvement in T cell proliferation, cytokine production, and integrin-mediated adhesion.PD-L2与PD-1参与T细胞增殖、细胞因子产生及整合素介导的黏附过程。
Eur J Immunol. 2005 Dec;35(12):3561-9. doi: 10.1002/eji.200526347.
5
Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection.霉酚酸酯预防急性和慢性移植排斥反应的作用机制。
Transplantation. 2005 Oct 15;80(2 Suppl):S181-90. doi: 10.1097/01.tp.0000186390.10150.66.
6
CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms.细胞毒性T淋巴细胞相关抗原4(CTLA-4)和程序性死亡受体1(PD-1)通过不同机制抑制T细胞活化。
Mol Cell Biol. 2005 Nov;25(21):9543-53. doi: 10.1128/MCB.25.21.9543-9553.2005.
7
The common gammac-cytokines and transplantation tolerance.常见的γc细胞因子与移植耐受
Cell Mol Immunol. 2004 Jun;1(3):167-72.
8
T-cell costimulatory pathways in allograft rejection and tolerance.同种异体移植排斥反应和耐受中的T细胞共刺激途径。
Transplantation. 2005 Sep 15;80(5):555-63. doi: 10.1097/01.tp.0000168432.60022.99.
9
Induction of transplantation tolerance-the potential of regulatory T cells.诱导移植耐受——调节性T细胞的潜力
Transpl Immunol. 2005 Aug;14(3-4):225-30. doi: 10.1016/j.trim.2005.03.011. Epub 2005 Apr 26.
10
Egr-2 and Egr-3 are negative regulators of T cell activation.早期生长反应蛋白2(Egr-2)和早期生长反应蛋白3(Egr-3)是T细胞活化的负调节因子。
Nat Immunol. 2005 May;6(5):472-80. doi: 10.1038/ni1193. Epub 2005 Apr 17.